Found: 18
Select item for more details and to access through your institution.
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 10, p. 1597, doi. 10.3390/cells11101597
- By:
- Publication type:
- Article
Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2425593, doi. 10.1001/jamanetworkopen.2024.25593
- By:
- Publication type:
- Article
Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant.
- Published in:
- Drug Development Research, 2016, v. 77, n. 7, p. 414, doi. 10.1002/ddr.21335
- By:
- Publication type:
- Article
Abnormal Development of Monoaminergic Neurons Is Implicated in Mood Fluctuations and Bipolar Disorder.
- Published in:
- Neuropsychopharmacology, 2015, v. 40, n. 4, p. 839, doi. 10.1038/npp.2014.244
- By:
- Publication type:
- Article
BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells.
- Published in:
- Journal of Neuroscience, 2018, v. 38, n. 7, p. 1662, doi. 10.1523/JNEUROSCI.1540-17.2018
- By:
- Publication type:
- Article
CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.650750
- By:
- Publication type:
- Article
The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia.
- Published in:
- Neuropathology & Applied Neurobiology, 2023, v. 49, n. 1, p. 1, doi. 10.1111/nan.12867
- By:
- Publication type:
- Article
Impact of NFIB and CYP1A variants on clozapine serum concentration--A retrospective naturalistic cohort study on 526 patients with known smoking habits.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 1, p. 62, doi. 10.1111/cts.13422
- By:
- Publication type:
- Article
Significantly lower CYP2D6 metabolism measured as the O/N‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 1, p. 194, doi. 10.1111/bcp.13788
- By:
- Publication type:
- Article
The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 5, p. 1165, doi. 10.1002/cpt.2571
- By:
- Publication type:
- Article
A Novel CYP2C‐Haplotype Associated With Ultrarapid Metabolism of Escitalopram.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 786, doi. 10.1002/cpt.2233
- By:
- Publication type:
- Article
Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 750, doi. 10.1002/cpt.2246
- By:
- Publication type:
- Article
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
- Published in:
- Frontiers in Psychiatry, 2020, p. 1, doi. 10.3389/fpsyt.2020.00094
- By:
- Publication type:
- Article
Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139697
- By:
- Publication type:
- Article
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2135, doi. 10.1111/cts.13347
- By:
- Publication type:
- Article
Corrigendum: Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool.
- Published in:
- Frontiers in Molecular Neuroscience, 2017, p. 1, doi. 10.3389/fnmol.2017.00372
- By:
- Publication type:
- Article